Scientists test copycat version of blockbuster arthritis drug
NCT ID NCT07147257
Summary
This study aimed to see if a new drug called CHS-1420 behaves the same way in the body as the established drug Humira (adalimumab). It involved 238 healthy Chinese adults who received a single dose of either drug. Researchers closely tracked the drug levels in the blood over time to compare them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ethics Committee of Hopeshine-Minsheng Hospital of Xinzheng
Zhengzhou, China
Conditions
Explore the condition pages connected to this study.